Baxter announces distribution agreement with bioMérieux for novel acute kidney injury diagnostic test in Europe and US
As part of the agreement, Baxter will be bioMérieux’s exclusive distributor of the NEPHROCLEAR CCL14 test in Europe…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Sep 20
As part of the agreement, Baxter will be bioMérieux’s exclusive distributor of the NEPHROCLEAR CCL14 test in Europe…
17 Sep 20
AXIM’s rapid diagnostic test is expected to be the market’s first Covid-19 rapid diagnostic test for measuring levels…
17 Sep 20
Regional CLIA-certified labs among growing nnumber of customers expanding SARS-CoV-2 testing with fluidigm technology
17 Sep 20
Breakthrough AI technology leads to precise surgery and optimal implant positioning, resulting in improved quality of life for…
17 Sep 20
Breakthrough platform utilizes 3D digital visualization, state-of-the-art software and augmentation capabilities which are unmatched by any competitor digital…
17 Sep 20
Signifier Medical Technologies is a medical technology company focused on the development and commercialization of innovative and non-invasive…
16 Sep 20
The acquisition is expected to enable Intersect ENT to provide a range of surgical solutions across the sinusitis…
16 Sep 20
MD Biosciences will validate and initiate commercial offering of lab testing to measure levels of COVID/Cytokine Storm-related cytokines
16 Sep 20
A total of 52 soluble immune mediators were examined as part of the development of the test
16 Sep 20
Smith+Nephew is a portfolio medical technology business that exists to restore people's bodies and their self-belief by using…